ASTERA LABS INC (ALAB) Fundamental Analysis & Valuation

NASDAQ:ALAB • US04626A1034

Current stock price

120.33 USD
-1.43 (-1.17%)
At close:
119.98 USD
-0.35 (-0.29%)
After Hours:

This ALAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ALAB Profitability Analysis

1.1 Basic Checks

  • In the past year ALAB was profitable.
  • In the past year ALAB had a positive cash flow from operations.
ALAB Yearly Net Income VS EBIT VS OCF VS FCFALAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • ALAB's Return On Assets of 14.31% is amongst the best of the industry. ALAB outperforms 86.09% of its industry peers.
  • ALAB has a better Return On Equity (16.07%) than 81.74% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.79%, ALAB belongs to the top of the industry, outperforming 80.87% of the companies in the same industry.
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROIC 9.79%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALAB Yearly ROA, ROE, ROICALAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • The Profit Margin of ALAB (25.70%) is better than 84.35% of its industry peers.
  • With a decent Operating Margin value of 20.34%, ALAB is doing good in the industry, outperforming 79.13% of the companies in the same industry.
  • ALAB has a better Gross Margin (75.69%) than 94.78% of its industry peers.
  • In the last couple of years the Gross Margin of ALAB has remained more or less at the same level.
Industry RankSector Rank
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
ALAB Yearly Profit, Operating, Gross MarginsALAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ALAB Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAB is destroying value.
  • ALAB has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALAB Yearly Shares OutstandingALAB Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M
ALAB Yearly Total Debt VS Total AssetsALAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • ALAB has an Altman-Z score of 75.84. This indicates that ALAB is financially healthy and has little risk of bankruptcy at the moment.
  • ALAB's Altman-Z score of 75.84 is amongst the best of the industry. ALAB outperforms 97.39% of its industry peers.
  • There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 75.84
ROIC/WACC0.85
WACC11.53%
ALAB Yearly LT Debt VS Equity VS FCFALAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • ALAB has a Current Ratio of 10.24. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 10.24, ALAB belongs to the top of the industry, outperforming 92.17% of the companies in the same industry.
  • ALAB has a Quick Ratio of 9.79. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
  • ALAB has a Quick ratio of 9.79. This is amongst the best in the industry. ALAB outperforms 92.17% of its industry peers.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 9.79
ALAB Yearly Current Assets VS Current LiabilitesALAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ALAB Growth Analysis

3.1 Past

  • ALAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.00%, which is quite impressive.
  • Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 115.13%.
  • The Revenue has been growing by 120.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.04% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALAB will show a very strong growth in Revenue. The Revenue will grow by 21.07% on average per year.
EPS Next Y34.94%
EPS Next 2Y38.18%
EPS Next 3Y35.37%
EPS Next 5Y35.04%
Revenue Next Year61.78%
Revenue Next 2Y49.37%
Revenue Next 3Y41.59%
Revenue Next 5Y21.07%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALAB Yearly Revenue VS EstimatesALAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ALAB Yearly EPS VS EstimatesALAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALAB Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 65.40, the valuation of ALAB can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as ALAB.
  • When comparing the Price/Earnings ratio of ALAB to the average of the S&P500 Index (25.61), we can say ALAB is valued expensively.
  • ALAB is valuated quite expensively with a Price/Forward Earnings ratio of 48.46.
  • ALAB's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.79, ALAB is valued quite expensively.
Industry RankSector Rank
PE 65.4
Fwd PE 48.46
ALAB Price Earnings VS Forward Price EarningsALAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • ALAB's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 72.69
EV/EBITDA 102.72
ALAB Per share dataALAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ALAB's earnings are expected to grow with 35.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.87
PEG (5Y)N/A
EPS Next 2Y38.18%
EPS Next 3Y35.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALAB Dividend Analysis

5.1 Amount

  • No dividends for ALAB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALAB Fundamentals: All Metrics, Ratios and Statistics

ASTERA LABS INC

NASDAQ:ALAB (3/25/2026, 8:10:12 PM)

After market: 119.98 -0.35 (-0.29%)

120.33

-1.43 (-1.17%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners79.38%
Inst Owner Change3.11%
Ins Owners10.44%
Ins Owner Change-6.11%
Market Cap20.48B
Revenue(TTM)852.52M
Net Income(TTM)219.13M
Analysts80.71
Price Target206.23 (71.39%)
Short Float %7.14%
Short Ratio2.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.96%
Min EPS beat(2)10.58%
Max EPS beat(2)23.34%
EPS beat(4)4
Avg EPS beat(4)20.27%
Min EPS beat(4)10.58%
Max EPS beat(4)33.19%
EPS beat(8)8
Avg EPS beat(8)91.39%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.89%
Min Revenue beat(2)6.34%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)6.73%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)8
Avg Revenue beat(8)8.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.68%
PT rev (3m)0.14%
EPS NQ rev (1m)3.31%
EPS NQ rev (3m)3.42%
EPS NY rev (1m)3.04%
EPS NY rev (3m)3.68%
Revenue NQ rev (1m)12.64%
Revenue NQ rev (3m)12.78%
Revenue NY rev (1m)12.28%
Revenue NY rev (3m)11.82%
Valuation
Industry RankSector Rank
PE 65.4
Fwd PE 48.46
P/S 24.02
P/FCF 72.69
P/OCF 64.14
P/B 15.02
P/tB 15.02
EV/EBITDA 102.72
EPS(TTM)1.84
EY1.53%
EPS(NY)2.48
Fwd EY2.06%
FCF(TTM)1.66
FCFY1.38%
OCF(TTM)1.88
OCFY1.56%
SpS5.01
BVpS8.01
TBVpS8.01
PEG (NY)1.87
PEG (5Y)N/A
Graham Number18.21
Profitability
Industry RankSector Rank
ROA 14.31%
ROE 16.07%
ROCE 12.4%
ROIC 9.79%
ROICexc 65.25%
ROICexgc 65.25%
OM 20.34%
PM (TTM) 25.7%
GM 75.69%
FCFM 33.05%
ROA(3y)-2.33%
ROA(5y)N/A
ROE(3y)-3.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5YN/A
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 549.77%
Cap/Sales 4.4%
Interest Coverage 250
Cash Conversion 177.14%
Profit Quality 128.58%
Current Ratio 10.24
Quick Ratio 9.79
Altman-Z 75.84
F-Score6
WACC11.53%
ROIC/WACC0.85
Cap/Depr(3y)596.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.76%
EPS Next Y34.94%
EPS Next 2Y38.18%
EPS Next 3Y35.37%
EPS Next 5Y35.04%
Revenue 1Y (TTM)115.13%
Revenue growth 3Y120.18%
Revenue growth 5YN/A
Sales Q2Q%91.77%
Revenue Next Year61.78%
Revenue Next 2Y49.37%
Revenue Next 3Y41.59%
Revenue Next 5Y21.07%
EBIT growth 1Y249.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.09%
EBIT Next 3Y41.83%
EBIT Next 5Y41.19%
FCF growth 1Y175.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y133.62%
OCF growth 3YN/A
OCF growth 5YN/A

ASTERA LABS INC / ALAB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ASTERA LABS INC?

ChartMill assigns a fundamental rating of 6 / 10 to ALAB.


Can you provide the valuation status for ASTERA LABS INC?

ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.


How profitable is ASTERA LABS INC (ALAB) stock?

ASTERA LABS INC (ALAB) has a profitability rating of 5 / 10.


Can you provide the financial health for ALAB stock?

The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.